ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

Centers Core Support To Be Trimmed By Dropping Funds for Scientists Salaries, Shared Resources

September 23, 1977

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006